Archives: Speakers

Kirsty has been with Nactarome Ltd for the last two years, working within the Beverage and Sweet sector to support customer growth and development. My Focus is on building strong relationships, understanding customer challenges and delivering innovative flavour solutions.

Dr Yvonne Tretter joined Novotech in 2017 – she has more than 20 years of experienced working in the CRO industry – holding various positions including Director Project Management, Clinical Operations and Project Director.​

She successfully managed many phase I, II & III, global and  international trials for top pharmaceutical and biotech companies and ensured the highest level of the deliverables.​

Yvonne gained her Dr. rer. Nat. in biology (neurobiology & biochemistry)​

Jennifer Holloway is a board-certified Nurse Practitioner with a Doctor of Nursing Practice and over 10 years of experience in critical care and clinical research. Her career has focused on delivering high-acuity care while advancing evidence-based practices through research and quality improvement initiatives. Mrs. Holloway is passionate about bridging the gap between bedside care and clinical inquiry, and she continues to advocate for innovative, patient-centered approaches within interdisciplinary teams. Her work reflects a deep commitment to clinical excellence, research integration, and the ongoing advancement of nursing practice.

Kerri oversees the global Functional Service Provider (FSP) biometrics team at Parexel, spanning North America, South America, EMEA, and APAC.

With tenure at Parexel of more than 28 years, Kerri has also overseen Parexel’s team of FSP solution consultants, and served in a commercial and sales support role and as a solution consultant herself. Kerri’s career at Parexel spans more than 19 years in operational management in statistical programming. She brings a wealth of expertise, a deep understanding of client needs, and a passion for operational excellence. Kerri holds a master’s degree in health studies from Brock University.

Mr. Andy Liu has strong operational experience in the CRO industry and a deep understanding of the regional market. Andy worked at Covance, Inc., a global CRO, for more than 10 years in a number of executive positions. Before joining PPC group, he was General Manager of Covance’s Central Laboratory Service, Asia Pacific, where he led a large multi-functional team of around 500 employees across multiple sites in APAC. Andy holds an MBA from the Booth School of Business at the University of Chicago, an MS in Electrical Engineering from the Rose-Hulman Institute of Technology, and a BS in Electrical Engineering from Tsinghua University.

Leila Cupersmith is a rare-disease and cancer clinical trial operations leader and patient-advocacy champion with 20+ years of clinical trial operations experience delivering highly complex cancer and rare-disease studies across Phases I–III, across more than 30 countries from concept through closure. Her work centers on innovative, nimble, cost and time-effective, operational, collaborative strategies that reduce patient and caregiver burden, embed transparent communication, and align site, CRO, sponsor, advocacy, and regulatory stakeholders early and often. In addition to ongoing global patient and caregiver-centered rare disease and cancer clinical trial operations, Leila also actively volunteers on various Committees contributing to telehealth/telemedicine standards and equity for clinical research, reflecting her focus on pragmatic decentralization pathways that protect data integrity while alleviating patient and care provider burden and expanding equitable access for small, geographically dispersed populations

Marouane Nouira is a seasoned clinical data management executive with a strong focus on driving AI and innovation within the life sciences sector. As Head of Data Management & Strategy at Galapagos, he leads strategic data initiatives across decentralized CAR-T oncology trials, integrating AI-driven approaches to optimize data workflows and cross-functional collaboration.

During his 13-year tenure as Vice President of Services at Medidata, Marouane pioneered the integration of AI, machine learning, and generative AI into clinical data management—delivering transformative efficiencies and securing patents for novel applications of AI in clinical data systems. 

Will spent the first half of his career working in craft beer production, including a tenure as head brewer, before moving to service the beer industry and beyond with technical sales of hop products. Now managing sweet and beverage business line at Nactarome UK he is well equipped to bring added value solutions to beverage manufacturers with Nactarome’s capabilities in innovative flavours and ingredients.

Tim O’Neill is Chief Operating Officer at SōRSE Technology, where he is responsible for the day-to-day execution of their corporate strategy, helping position them as the global leader in water soluble cannabinoids. He joined SōRSE following ten years as an officer in the British Army, where he enjoyed a broad range of roles from policy to counter insurgency operations. He has worked with military, civic and commercial partners in Europe, the United States, the Middle East, Central Asia, Africa and South East Asia.